Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Harris

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationshipsM Nakane, J A Reid, M F Haslanger, et al.
The British Journal of Radiology|April 1, 1981
left ventricular segmental wall motion-a comparison between equilibrium radionuclide angiography and contrast angiographyD N Harris, D N Taylor, B C Ogilvie, et al.
Journal of Medicinal Chemistry|September 1, 1991
Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chainsR N Misra, B R Brown, W C Han, et al.
Thrombosis Research|August 1, 1981
Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood plateletsD N Harris, M B Phillips, I M Michel, et al.
European Journal of Pharmacology|August 3, 1984
Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscleD N Harris, R Greenberg, M B Phillips, et al.
Prostaglandins|August 1, 1981
9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptorD N Harris, M B Phillips, I M Michel, et al.
AJR. American Journal of Roentgenology|November 1, 1996
Laser ablation of the endometrium: MR appearance during and after treatment and the relation of MR appearance to clinical outcomeN M deSouza, D L McMillan, R K Puni, et al.
Prostaglandins|April 1, 1986
Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analogD N Harris, M B Phillips, I M Michel, et al.
Japanese Journal of Pharmacology|April 1, 1979
Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive ratsM J Antonaccio, B Rubin, Z P Horovitz, et al.
European Journal of Pharmacology|October 15, 1978
Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive ratsB Rubin, M J Antonaccio, M E Goldberg, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationshipsM Nakane, J A Reid, M F Haslanger, et al.
The British Journal of Radiology|April 1, 1981
left ventricular segmental wall motion-a comparison between equilibrium radionuclide angiography and contrast angiographyD N Harris, D N Taylor, B C Ogilvie, et al.
Journal of Medicinal Chemistry|September 1, 1991
Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chainsR N Misra, B R Brown, W C Han, et al.
Thrombosis Research|August 1, 1981
Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood plateletsD N Harris, M B Phillips, I M Michel, et al.
European Journal of Pharmacology|August 3, 1984
Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscleD N Harris, R Greenberg, M B Phillips, et al.
Prostaglandins|August 1, 1981
9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptorD N Harris, M B Phillips, I M Michel, et al.
AJR. American Journal of Roentgenology|November 1, 1996
Laser ablation of the endometrium: MR appearance during and after treatment and the relation of MR appearance to clinical outcomeN M deSouza, D L McMillan, R K Puni, et al.
Prostaglandins|April 1, 1986
Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analogD N Harris, M B Phillips, I M Michel, et al.
Japanese Journal of Pharmacology|April 1, 1979
Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive ratsM J Antonaccio, B Rubin, Z P Horovitz, et al.
European Journal of Pharmacology|October 15, 1978
Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive ratsB Rubin, M J Antonaccio, M E Goldberg, et al.
Pageof 7